DRZK
Razak PharmaceuticalShares | Bourse | Pharmaceuticals
You are a visitor: prices in full, the rest as a preview You see 1 year of statements, the 3 largest holders and the 3 latest events; each part shows where the rest would be.Create a free account
Sahmino's view
The view, its invalidation and its record, after a free sign-up.
Sahmino scoreSahmino's score is five checks: value, quality, trend, tradability and risk. Each check runs a few tests on this symbol's readings and passes when every test that could be read passes. Each passed check fills one cell of the bar, and a check none of whose tests could be read is left out of the count. The readings are the screener's columns, Sahmino's view for today and the symbol's state on the board.
Fair value
Five methods, your own assumptions and versions; 60 runs a monthSee what it gives you
The board and technical statistics show at the «intermediate» and «expert» levels; change it in Account › Appearance.
Key figures
TSE first market, secondary board | Pharmaceuticals- Market cap
- 134 trillion rials
- P/E
- 9.2
- Group 11.5
- EPS (12 months)
- 834 rials
- P/S
- 3.44
- Last dividend per share
- 100 rials
- Yield 1.3%
- Free float
- 44%
- Value traded, last session
- 106 billion rials
- Value vs 20-session average
- 0.2×
- Net retail money
- +70.2 billion rials
- 52-week range
- 1,342 to 7,670
- At its 52-week high
- Largest recent drawdown
- −65.6%
- 6 May to 7 April
- Correlation with the dollar (90 days)
- 0
Returns over periods, in rials and in dollars
Today
up3.0%1W
up12.3%USD +13.8%
1M
up25.9%USD +27.4%
3M
up92.7%USD +36.5%
6M
up448.6%USD +270.6%
YTD
up448.6%USD +222.1%
1Y
up413.0%USD +118.4%
3Y
up474.6%USD +8.4%
5Y
up433.1%USD −43.1%
Closing price change only; dividends and rights are not counted in these figures.
Why did it move? A 52-week high, opened with a gap up, 8 rising sessions in a row. Value traded was 0.2× its twenty-session average. Individuals made 89% of the buying and 23% of the selling. Ranks 80 of 895 in its market by today's change, counting from the biggest rise. Candidates, never a cause: board events, the group, the market and the last three days' filings.
About this symbol
All- DRZKCodal7,670up3.0%افشای اطلاعات بااهمیت - (تغییر در مفاد هر نوع اطلاعیه بااهمیتی که قبلاً منتشر شده است - گروه ب) منتهی به سال مالی ۱۴۰۵/۱۲/۲۹11 November
- DRZKNews7,670up3.0%Razak Laboratories (DRZK) Discloses Higher Average Selling Prices for Human and Veterinary Medicines11 November
- DRZKCodal7,670up3.0%افشای اطلاعات بااهمیت - (تغییر در نرخ فروش محصولات یا ارائه خدمات – گروه الف) منتهی به سال مالی ۱۴۰۵/۱۲/۲۹11 November
- DRZKCodal7,670up3.0%گزارش فعالیت ماهانه دوره ۱ ماهه منتهی به ۱۴۰۵/۰۷/۳۰28 October
- DRZKNews7,670up3.0%Razak Clarifies Capacity of New Tablet Line in Updated Filing18 October
- DRZKNews7,670up3.0%Razak Pharmaceutical Starts Tablet Line Under Food and Drug Administration Permit18 October
Peers
8CompareFollow DRZK; we tell you every move that matters Free. You stay right here, and this symbol is followed once you sign up.
